Loading...
newstechnology
OpenAI CEO Tackles AI Concerns, BlueFocus Aims for AI Marketing Dominance, NHS Trials AI Note-Taking Tool, Lightrun Secures 70M Series B, and more...
About this Episode
OpenAI CEO Addresses Concerns Over ChatGPT's 'Sycophantic' Behavior and AI Manipulation Risks
BlueFocus Targets Global AI Marketing Dominance with 15.55% Revenue Surge and New Strategies
UK NHS Trials AI Note-Taking Tool to Revolutionize Patient Care and Reduce Bureaucracy
Lightrun Secures $70M Series B to Revolutionize Real-Time Code Fixing with AI
Glacier Secures Funding to Revolutionize U.S. Recycling with AI Robots, Expands to Seattle
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Digital Watch Observatory
Hosts & Guests
No transcript available for this episode.
